We have shown anticancer activity in several pancreatic cancer models as a unimodal treatment and a synergistic antitumor effect when combined with gemcitabine through an NF-kB mediated mechanism of uPAR promoter activation [11–13]. The gene discussed is PLAUR; the disease is familial pancreatic carcinoma.